CD274 and nonpapillary renal cell carcinoma: It has been demonstrated that previous genomic correlations of ICB responses in solid tumors (TMB and PD-L1 status, etc.)cannot predict ccRCC, suggesting the important role of the immune microenvironment in modulating clinical benefits (39–41).